High levels of cytokine-producing cells in the lung tissues of patients with fatal hantavirus pulmonary syndrome

Journal of Infectious Diseases

Volumn 179, Issue 2, 1999, Pages 295-302

  Mori, Masuko ^a   Rothman, Alan L ^d   Kurane, Ichiro ^b   Montoya, James M ^d   Nolte, Kurt B ^d   Norman, Joyce E ^d   Waite, Douglas C ^d   Koster, Frederick T ^d   Ennis, Francis A ^c  

^a Fukujuji Medical Center   (Japan)

^b NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^c UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; LYMPHOTOXIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; AGED; ARTICLE; CAPILLARY ENDOTHELIUM; CAPILLARY LEAK SYNDROME; CLINICAL ARTICLE; CYTOKINE PRODUCTION; FATALITY; FEMALE; HANTAVIRUS PULMONARY SYNDROME; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG EDEMA; LUNG PARENCHYMA; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SPLEEN;

ADULT; AGED; CYTOKINES; FEMALE; HANTAVIRUS PULMONARY SYNDROME; HUMANS; INFANT, NEWBORN; INTERFERONS; INTERLEUKINS; KIDNEY; LIVER; LUNG; MALE; MIDDLE AGED; SPLEEN;

EID: 0032977170     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/314597     Document Type: Article

References (36)

1. Centers for Disease Control and Prevention. Outbreak of acute illness - southwestern United States, 1993. MMWR CDC Surveill Summ 1993;42:421-4
2. Wrobel S. Serendipity, science, and a new hantavirus. FASEB J 1995;9:1247-54.
3. Duchin JS, Koster FT, Peters CJ, et al. Hantavirus pulmonary syndrome: a clinical description of 17 patients with a newly recognized disease. N Engl J Med 1994;330:949-55.
4. Jenison S, Hjelle B, Simpson S, Hallin G, Feddersen R, Koster F. Hantavirus pulmonary syndrome: clinical, diagnostic, and virologic aspects. Semin Respir Infect 1995;10:259-69.
5. Butler JC, Peters CJ. Hantaviruses and hantavirus pulmonary syndrome. Clin Infect Dis 1994;19:387-94.
6. Khan AS, Ksiazek TG, Peters CJ. Hantavirus pulmonary syndrome. Lancet 1996;347:739-41
7. Morse SS. Hantaviruses and the hantavirus outbreak in the United States. A case study in disease emergence. Ann NY Acad Sci 1994;740:199-207.
8. Zaki SR, Greer PW, Coffield LM, et al. Hantavirus pulmonary syndrome. Pathogenesis of an emerging infectious disease. Am J Pathol 1995;146:552-79.
9. Nuovo GJ, Simsir A, Steigbigel RT, Kuschner M. Analysis of fatal pulmonary hantaviral infection in New York by reverse transcriptase in situ polymerase chain reaction. Am J Pathol 1996;148:685-92.
10. Hjelle B, Jenison SA, Goade DE, Green WB, Feddersen RM, Scott AA. Hantaviruses: clinical, microbiologic, and epidemiologic aspects. Crit Rev Clin Lab Sci 1995;32:469-508
11. Kurane I, Rothman AL, Livingston PG et al. Immunopathologic mechanisms of dengue hemorrhagic fever and dengue shock syndrome. Arch Virol 1994;9:59-64.
12. Kurane I, Ennis FA. Cytokines in dengue virus infections: role of cytokines in the pathogenesis of dengue hemorrhagic fever. Semin Virol 1994;5:443-8.
13. Kurane I, Innis BL, Nimmannitya S, et al. Activation of T lymphocytes in dengue virus infections. High levels of soluble interleukin 2 receptor, soluble CD4, soluble CD8, interleukin 2, and interferon-gamma in sera of children with dengue. J Clin Invest 1991;88:1473-80
14. Hober D, Delannoy AS, Benyoucef S, De Groote D, Wattre P. High levels of sTNFR p75 and TNF alpha in dengue-infected patients. Microbiol Immunol 1996;40:569-73.
15. Linderholm M, Ahlm C, Settergren B, Waage A, Tarnvik A. Elevated plasma levels of tumor necrosis factor (TNF)-α, soluble TNF receptors, interleukin (IL)-6, and IL-10 in patients with hemorrhagic fever with renal syndrome. J Infect Dis 1996;173:38-43.
16. Mori M, Kurane I, Janus J, Ennis FA. Cytokine production by dengue virus antigen-responsive human T lymphocytes in vitro examined using a double immunocytochemical technique. J Leukoc Biol 1997;61:338-45.
17. Andersson J, Andersson U. Characterization of cytokine production in infectious mononucleosis studied at a single-cell level in tonsil and peripheral blood. Clin Exp Immunol 1993;92:7-13
18. Nolte KB, Feddersen RM, Foucar K, et al. Hantavirus pulmonary syndrome in the United States: a pathological description of a disease caused by a new agent. Hum Pathol 1995;26:110-20.
19. Kurane I, Ennis FA. Immunity and immunopathology in dengue virus infections. Semin Immunol 1992;4:121-7
20. Tracey KJ, Cerami A. Tumor necrosis factor, other cytokines and disease. Ann Rev Cell Biol 1993;9:317-43
21. Kelley J. Cytokines of the lung. Am Rev Respir Dis 1990;141:765-88.
22. Thijs LG, Hack CE, Strack van Schijndel RJM, et al. Activation of the complement system during immunotherapy with recombinant IL-2. Relation to the development of side effects. J Immunol 1990;144:2419-24.
23. Nedwin GE, Svedersky LP, Bringman TS, Palladino MA Jr, Goeddel DV. Effect of interleukin 2, interferon-γ, and mitogens on the production of tumor necrosis factors α and Β J Immunol 1985;135:2492-7.
24. Kurata T, Tsai TF, Bauer SP, McCormick JB. Immunofluorescence studies of disseminated Hantaan virus infection of suckling mice. Infect Immun 1983;41:391-8.
25. Ping Z, Wei-song Y. Effects of Hantaan virus on human endothelial cells and their significance in pathogenesis of hemorrhagic fever with renal syndrome. Chinese Med J 1991;104:924-9.
26. Huang C, Jin B, Wang M, Li E, Sun C. Hemorrhagic fever with renal syndrome: relationship between pathogenesis and cellular immunity. J Infect Dis 1994;169:868-70.
27. Cosgriff TM. Mechanisms of disease in hantavirus infection: pathophysiology of hemorrhagic fever with renal syndrome. Rev Infect Dis 1991;13:97-107.
28. Chen L, Wang W. Abnormalities of T cell immunoregulation in hemorrhagic fever with renal syndrome. J Infect Dis 1990;161:I016-9
29. Papadimitriou M. Hantavirus nephropathy. Kidney Int 1995;48:887-902.
30. Hjelle B, Goade D, Torrez-Martinez N, et al. Hantavirus pulmonary syndrome, renal insufficiency, and myositis associated with infection by Bayou hantavirus. Clin Infect Dis 1996;23:495-500.
31. Khan AS, Gaviria M, Rollin PE, et al. Hantavirus pulmonary syndrome in Florida: association with the newly identified Black Creek Canal virus. Am J Med 1996;100:46-8.
32. Hjelle B, Spiropoulou CF, Torrez-Martinez N, Morzunov S, Peters CJ, Nichol ST. Detection of Muerto Canyon virus RNA in peripheral blood mononuclear cells from patients with hantavirus pulmonary syndrome. J Infect Dis 1994;170:1013-7.
33. Shenkar R, Coulson WF, Abraham E. Hemorrhage and resuscitation induce alterations in cytokine expression and the development of acute lung injury. Am J Respir Cell Mol Biol 1994;10:290-7.
34. Hempel SL, Monick MM, Hunninghake GW. Effect of hypoxia on release of IL-I and TNF by human alveolar macrophages. Am J Respir Cell Mol Biol 1996;14:170-6.
35. Abraham E, Jesmok G, Tuder R, Allbee J, Chang YH. Contribution of tumor necrosis factor-α to pulmonary cytokine expression and lung injury after hemorrhage and resuscitation. Crit Care Med 1995;23:1319-26.
36. Suter PM, Suter S, Girardin E, Roux-Lombard P, Grau GE, Dayer JM. High bronchoalveolar levels of tumor necrosis factor and its inhibitors, inter]eukin-1, interferon, and elastase, in patients with adult respiratory distress syndrome after trauma, shock, or sepsis. Am Rev Respir Dis 1992;145:1016-22.